利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

1109 条记录 (耗时 0.034 秒)

    DYNAMIC HEALTHCARE SYSTEM FOR SPASMODIC CLINICAL WORKFLOWS
    2.
    发明公开
    DYNAMIC HEALTHCARE SYSTEM FOR SPASMODIC CLINICAL WORKFLOWS 审中-公开

    公开(公告)号：US20240331852A1

    公开(公告)日：2024-10-03

    申请号：US18191778

    申请日：2023-03-28

    申请人： Ethicon, Inc.

    发明人： Manikandan Rajappa ,  Shantha Andrews

    IPC分类号： G16H40/20 ,  G06F40/205 ,  G16H10/60

    CPC分类号： G16H40/20 ,  G06F40/205 ,  G16H10/60

    摘要： A healthcare system accommodates spasmodic clinical workflows for populating a records database associated with a surgical platform or other digital healthcare platform. An interoperability engine receives data streams including events from various electronic health records systems that provide data events according to varying format, order, and timing dependent on their corresponding clinical workflows. The interoperability engine maps indeterminate events to expected events associated with a clinical workflow based on a clinical workflow management file, an industry standard model, a general parsing model, or a combination thereof. The interoperability engine may furthermore detect non-compliance of received events and may generate feedback indicative of a compliance assessment.

    Medical product storage device
    4.
    外观设计
    Medical product storage device 有权

    公开(公告)号：USD1042639S1

    公开(公告)日：2024-09-17

    申请号：US29870310

    申请日：2023-01-20

    申请人： Ethicon, Inc.

    设计人： Jonathan Syby ,  Matthew Chila ,  David Wade ,  Kevin McHale ,  Alex Weber

    摘要： FIG. 1 is a top perspective view of the medical product storage device showing our new design;
    FIG. 2 is a bottom perspective view thereof;
    FIG. 3 is a front elevation view thereof;
    FIG. 4 is a back elevation view thereof;
    FIG. 5 is a side elevation view thereof;
    FIG. 6 is the opposite side elevation view thereof;
    FIG. 7 is a top plan view thereof; and,
    FIG. 8 is a bottom plan view thereof.
    The broken lines show portions of the article that form no part of the claimed design.

    MEDICAL SEALANTS
    5.
    发明公开
    MEDICAL SEALANTS 审中-公开

    公开(公告)号：US20240299617A1

    公开(公告)日：2024-09-12

    申请号：US18178837

    申请日：2023-03-06

    申请人： Ethicon, Inc.

    发明人： Salim A. Ghodbane

    IPC分类号： A61L24/04 ,  A61L24/00

    CPC分类号： A61L24/043 ,  A61L24/0042

    摘要： Disclosed is a sealant, and techniques for making and using the sealant. The sealant may include three components that, when combined, produce the sealant: an electrophilic component, a nucleophilic component, and a doping component. The electrophilic component may include a first electrophilic material having a first functionality of a first reactive group. The nucleophilic component may include a first nucleophilic material having a second functionality of a second reactive group. The doping component may include a second electrophilic material having a third functionality of the first reactive group greater than the first functionality and/or a second nucleophilic material having a fourth functionality of the second reactive group greater than the second functionality. The doping component may be present in an amount sufficient to provide a 2-20% molar contribution of the first reactive group and/or the second reactive group in the sealant.

    EXPANDABLE HEMOSTATIC TABLETS COMPRISING OXIDIZED REGENERATED CELLULOSE
    8.
    发明公开
    EXPANDABLE HEMOSTATIC TABLETS COMPRISING OXIDIZED REGENERATED CELLULOSE 审中-公开

    公开(公告)号：US20240148933A1

    公开(公告)日：2024-05-09

    申请号：US18053628

    申请日：2022-11-08

    申请人： Ethicon, Inc.

    发明人： Yi-Lan Wang ,  Tien-Jung Lee

    IPC分类号： A61L15/28

    CPC分类号： A61L15/28 ,  A61L2400/04

    摘要： The present invention is directed to compressed hemostatic tablets or forms comprising a fibrous non-woven oxidized cellulose (OC or ORC) multilayer material compressed into a form stable tablet, further comprising calcium salt, with the tablets rapidly expandable on contact with blood or blood plasma. The compressed forms may further comprise a multi-arm PEG-SG and are dimensionally, preferably with regard to length and width, stable for at least 48 hours after compression. In some embodiments, the compressed forms will expand upon contact with blood from 1.5 to 5 times of tablet length in 5 seconds; from 2 to 6 times of tablet length in 20 seconds; and from 3 to 6 times of tablet length in 5 minutes. The compressed forms are effective in hemostasis in heparinized blood.